PLCZ1
protein-codingphospholipase C zeta 1, the group of EF-hand domain containing|Phospholipases|C2 domain containing phospholipases
Gene summary
The protein encoded by this gene is a member of the phosphoinositide-specific phospholipase C family. Members in this family, classified into six isotypes that are tissue- and organ-specific, hydrolyze phosphatidylinositol 4,5-bisphosphate just before the phosphate group to yield diacylglycerol and inositol 1,4,5-trisphosphate. This protein localizes to the acrosome in spermatozoa and elicits Ca(2+) oscillations and egg activation during fertilization that leads to early embryonic development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~54.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014970
Submitter: ClinGen
*PLCZ1* was first reported in relation to male infertility due to fertilization failure in 2009 (Heytons *et al.*, PMID: 19584136). Note, this disease concept is currently represented by the term “spermatogenic failure 17”. However, the new term (male infertility due to fertilization failure) has been requested by the Male Infertility GCEP because the primary mechanism associated with *PLCZ1* variants is impaired oocyte activation, resulting in fertilization failure. In the original paper, an autosomal dominant mode of inheritance was originally proposed as only a single heterozygous variant was identified in the patient. However, later Kashir et al. found a second variant in trans reported in the same patient, confirming an autosomal recessive inheritance pattern. Eleven variants (five loss-of-function and six missense) that have been reported in six probands in four publications (PMIDs: 36529831, 32048714, 31953539, 22095789) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. The underlying mechanistic effect is that an absent or impaired *PLCZ1* does not induce calcium release from the ER within the oocyte (PMID:12117804, 12416999). Thus, oocyte activation, fertilization and embryonic development fail. This gene-disease relationship is also supported by experimental evidence (e.g. animal models, expression studies, in vivo functional assays, and biochemical function) (PMIDs: 29358633, 12416999, 12117804, 32923619, 35863052). In summary, there is definitive evidence supporting the relationship between *PLCZ1* and autosomal recessive male infertility due to fertilization failure. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Male Infertility GCEP on the meeting date May 20, 2026 (SOP Version 12).
Inheritance Pattern: AR
Disease ID:MONDO:0014970
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Genitourinary
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PLCZ1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_033123.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 5 | ||||
| missense | 4 | 2 | 66 | 4 | 1 | 77 |
| nonsense | 1 | 3 | 1 | 5 | ||
| start loss | 0 | |||||
| frameshift | 2 | 1 | 1 | 4 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 8 | 7 | 68 | 9 | 1 | 93 |
Highest pathogenic variant AF is 0.00013702553
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_149114.2 | 14 | MANE Select | |
| Ensembl | ENSP00000266505.7 | 14 | MANE Select | |
| RefSeq | NP_001317698.1 | 11 | Standard | |
| RefSeq | NP_001317703.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Inositol phosphate metabolism - Homo sapiens (human)
- Oocyte meiosis - Homo sapiens (human)
- Thyroid hormone signaling pathway - Homo sapiens (human)
- Calcium signaling pathway - Homo sapiens (human)
- Phosphatidylinositol signaling system - Homo sapiens (human)
Biological Process
- calcium ion transport
- positive regulation of cytosolic calcium ion concentration
- multicellular organism development
- egg activation
- lipid catabolic process
Molecular Function
- phosphatidylinositol phospholipase C activity
- calcium ion binding
- phosphatidylinositol-4,5-bisphosphate binding
- phosphatidylinositol-5-phosphate binding
- phosphatidylinositol-3-phosphate binding
Cellular Component
- nucleus
- nucleoplasm
- nucleolus
- cytosol
- pronucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000266505
- Coding exons
- 14
- Length
- 54889
- Individuals with no LoFs
- 125646
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 93
- Defined
- 125739
- p
- 0.000370
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.608 | 342 | 312 | 1.10 | 0.0000153 | 4017 |
| Missense (PolyPhen) | 121 | 120.16 | 1.007 | 1634 | ||
| Synonymous | -0.756 | 112 | 102 | 1.10 | 0.00000482 | 1076 |
| Loss of Function | 1.44 | 23 | 31.8 | 0.723 | 0.00000157 | 417 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00060 | 0.00060 | rare |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.00053 | 0.00052 | rare |
| South Asian | 0.00023 | 0.00023 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. In vitro, hydrolyzes PtdIns(4,5)P2 in a Ca(2+)- dependent manner. Triggers intracellular Ca(2+) oscillations in oocytes solely during M phase and is involved in inducing oocyte activation and initiating embryonic development up to the blastocyst stage. Is therefore a strong candidate for the egg- activating soluble sperm factor that is transferred from the sperm into the egg cytoplasm following gamete membrane fusion. May exert an inhibitory effect on phospholipase-C-coupled processes that depend on calcium ions and protein kinase C, including CFTR trafficking and function. {ECO:0000250|UniProtKB:Q8K4D7, ECO:0000269|PubMed:12416999, ECO:0000269|PubMed:14697805, ECO:0000269|PubMed:15579586, ECO:0000269|PubMed:26721930, ECO:0000305}.;
- Disease
- DISEASE: Spermatogenic failure 17 (SPGF17) [MIM:617214]: An autosomal recessive infertility disorder due to failure of oocyte activation and fertilization by sperm that otherwise exhibits normal morphology. {ECO:0000269|PubMed:26721930}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0925
Intolerance Scores
- LoFtool
- 0.949
- RVIS EVS
- -0.47
- RVIS percentile EVS
- 23.51
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.135
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |